Skip to main content

Cancer Research Services for Industry

The Centre has a strong research base that investigates disease processes with regards to cancer’s molecular heterogeneity, the architecture of the tumour microenvironment and the identification of biomarkers associated with therapeutic success and failure.​

The Centre aligns with the Health Innovation strategic theme at NTU and the Centre for Systems, Health and integrated Metabolic Research and sits in NTU’s School of Science and Technology.

The John van Geest Cancer Research center is now available through MTIF.

Cutting Edge Equipment

The John van Geest Cancer research centre is home to some of the most advanced cancer research equipment in the UK. The John van Geest centre also holds a Human Tissue Authority licence (HTA licence).

Forefront of Cancer Research

With the aim to save lives and speed recovery by improving the early diagnosis and treatment of cancer. The John Van Geest Cancer Research centre’s mission is to turn biomedical discovery into health and benefit for patients. With current focuses on the research areas:

  • Cancer Cell Signalling and Therapeutic Response
  • Underpinning OMICS Technologies and Computational Biology
  • Brain Tumour Development and Therapeutics
  • Non-coding RNAs and Epigenetics in Cancer
  • Cancer Vaccines
  • Genomics-Guided Cancer Immunotherapy

Explore more

Microscopy

Drug development and discovery

MTIF’s unique mixture of specialist equipment, facilities and expertise enables us to offer research and consultation services for a variety of drug development and discovery techniques.

Hamamatsu cytotoxicity testing

Clinical Research Services

MTIF stands at the forefront of clinical research – discover how MTIF can assist your needs.